Taking Baby Aspirin Improves Overall Survival for Patients With Head & Neck, Lung Cancer

Roswell Park researchers present findings at ASTRO Annual Meeting

• Aspirin improved overall survival for patients with head/neck, lung cancers
• Patients in both studies also received radiation or chemoradiation…
  

  Read the full article here

  Source: www.oncologytube.com

  Categories: Hem/Onc News and Journals
  Tweets with this article

  

  Oncology Tube

  Taking Baby Aspirin Improves Overall Survival for Patients With Head & Neck, Lung Cancer: Roswell Park researchers present findings at ASTRO Annual Meeting Aspirin improved overall survival for patients with head/neck, lung cancers Patients in both… https://t.co/IqQg0jI1EY https://t.co/uE8bsyY1vt

  Related Articles

  Cancer Warrior T-Shirt – OncologyTube – Unisex

  Rock the Cancer Warrior T-Shirt! Bold, comfy, and perfect for researchers, nurses, oncologists, and patients. Available in 10 colors—proceeds support cancer awareness. Wear your strength!…

  

  Oncology Tube March 7, 2025

  Steve Jobs Death, in 2025 could oncologist save him from pancreatic cancer?

  Reflecting on Steve Jobs death, we examine his cancer journey and the evolution of treatments. What if he had today’s options?

  

  Oncology Tube February 22, 2025

  Enfortumab Vedotin Plus Pembrolizumab vs. Chemotherapy for Untreated la/mUC: EV-302 Study Update

  Dr. Thomas Powles, MBBS, MRCP, MD, from Barts Cancer Institute at Queen Mary University of Londonon February 17, 2025 At the 2025 ASCO Genitourinary Cancers…

  

  Oncology Tube February 18, 2025

  Encorafenib + cetuximab (EC) BREAKWATER Study Reveals Breakthrough in Treating BRAF V600E-Mutant Metastatic Colorectal Cancer

  Exciting findings from the BREAKWATER study: encorafenib and cetuximab combination therapy improves treatment outcomes for patients with BRAF V600E-mutant metastatic colorectal cancer.

  

  Oncology Tube February 17, 2025

  Nivolumab: Does the Extended CheckMate-274 Results Prove It’s the Ultimate for MIBC? ASCO GU 2025

  The Nivolumab CheckMate-274 trial reveals promising data on overall survival in muscle-invasive bladder cancer.

  

  Oncology Tube February 17, 2025

  FDA Approves Adcetris / brentuximab vedotin + lenalidomide & rituximab in relapsed or refractory LBCL: Could This Change Standard Care?

  The FDA approves Adcetris in a new therapy for adults with relapsed Large B-cell Lymphoma, improving overall survival rates.

  

  Oncology Tube February 13, 2025

  FDA Approves Daiichi Sankyo datopotamab / Datroway for Advanced Breast Cancer – Key Trial Data

  The FDA has recently approved a game-changing treatment for breast cancer patients. In this video, we break down the approval of datopotamab deruxtecan-dlnk,…

  

  Oncology Tube February 9, 2025

  Can Imlunestrant Change the Future of Breast Cancer Treatment? Insights from SABCS with Virginia Kaklamani, MD

  Learn about the game-changing EMBER-3 trial. Dive into the results of Imlunestrant, a groundbreaking SERD for ER+, HER2- Advanced Breast Cancer.

  

  Oncology Tube February 9, 2025

  FGFR2 Mutations and IDH1 Real-World Data Suggests Caution with Immunotherapy in Specific mBTC

  Explore the latest findings from a real-world data analysis on the effectiveness of immunotherapy in treating metastatic biliary tract cancer (mBTC) with spe…

  

  Oncology Tube February 6, 2025

  PDAC with ctDNA Study on RMC-6236 Shows Promising Results at ASCO GI – Ignacio Garrido-Laguna, MD

  Welcome to OncologyTube.com, where we bring you the latest in oncology research and treatment breakthroughs. In this video, we feature an insightful intervie…

  

  Oncology Tube February 5, 2025